Alnylam Pharmaceuticals, Inc. (ALNY)
NASDAQ: ALNY · Real-Time Price · USD
231.22
+7.19 (3.21%)
Oct 26, 2026, 11:26 AM EDT - Market open
Alnylam Pharmaceuticals Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| TD Cowen | TD Cowen | Buy Maintains $482 | Buy | Maintains | $482 | +108.46% | Oct 21, 2026 |
| UBS | UBS | Buy Maintains $550 → $354 | Buy | Maintains | $550 → $354 | +53.10% | Oct 14, 2026 |
| Wells Fargo | Wells Fargo | Hold Maintains $256 → $253 | Hold | Maintains | $256 → $253 | +9.42% | Oct 14, 2026 |
| Citi | Citi | Buy Maintains $340 → $320 | Buy | Maintains | $340 → $320 | +38.40% | Oct 14, 2026 |
| Barclays | Barclays | Buy Maintains $450 | Buy | Maintains | $450 | +94.62% | Oct 13, 2026 |
| Bank of America Securities | Bank of America Securities | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Oct 9, 2026 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $300 | Hold | Maintains | $300 | +29.75% | Oct 9, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $350 → $345 | Buy | Maintains | $350 → $345 | +49.21% | Oct 8, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.